Ischemia-modified albumin is a nonspecific marker of ischemia that cannot differentiate between myocardial and skeletal muscle damage.
Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.
No takes yet. Share an insight, caveat, or question.
Michae l I Kalinski (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: